Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H
- 23 June 1998
- journal article
- Published by Elsevier
- Vol. 22 (2) , 185-191
- https://doi.org/10.1016/s0145-2126(97)00158-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- In vivo‘Purging’ of residual disease in CLL with Campath‐1HBritish Journal of Haematology, 1997
- Subcutaneous CAMPATH‐1H in fludarabine‐resistant/relapsed chronic lymphocytic and B‐prolymphocytic leukaemiaBritish Journal of Haematology, 1997
- Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.Journal of Clinical Pathology, 1996
- Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometryBritish Journal of Haematology, 1996
- Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemiaBritish Journal of Haematology, 1996
- Primary Structure of CD52Journal of Biological Chemistry, 1995
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991
- The CAMPATH‐1 antigen (CDw52)Tissue Antigens, 1990
- Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal AntibodiesLeukemia & Lymphoma, 1990
- Model system evaluating fluorescein‐labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometersCytometry, 1989